Pfizer Inc., 10% Owner at Mirna Therapeutics, Inc. (MIRN), bought 2,489,364 shares at $7.00 ($6.7M) on 2015-10-06, disclosed to the SEC on 2015-10-07.
Open-market purchase of $6.7M MIRN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,539,224 | $0 | 0.0% |
| 2 | $7.00 | 235,855 | $1.7M | 24.8% |
| 3 | $7.00 | 714,285 | $5.0M | 75.2% |
| Total | $2.67 avg | 2,489,364 | $6.7M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $900K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $1.0M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |